MD-920

SynDRA canonical compound SYN1955497 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	AADACL2
Mechanism of action	NFkB pathway inhibitor

All known targets

AADACL2

Mechanisms of action (all sources)

NFkB pathway inhibitor

Cross-references

Synonyms

Gibberellic acid + salt (topical, wound healing/venous ulcer), Aus Bio

Look up MD-920 in the interactive SynDRA portal →